At first, they were extremely hard to get, and patients were having to pay at least $400 a month for prescriptions, a very high price at the time
Sex hormone-binding globulin (SHBG) as an early biomarker and therapeutic target in polycystic ovary syndrome
Concentration tells you how much active tirzepatide the pharmacy dissolved into each milliliter
Birth control is required if you can become pregnant
According to Goldman Sachs latest research report, the global weight-loss drug market is expected to reach USD 114 billion by 2030, an upward revision of approximately 13% from its December forecast of USD 101 billion, driven by a confluence of favorable factors propelling the sectors evolution from a 'niche, premium-priced market' toward a 'mass consumer market.' Oral formulations are emerging as the most significant driver of industry growth, substantially lowering the barrier to adoption for the large population of patients unwilling to undergo long-term injectable therapies
Eating substantially less after starting a GLP-1 medicine may make an existing shortfall more likely to become symptomatic
